ClinicalTrials.gg
Drug

Lutropin alfa clinical trials

Also written Luveris.

studies test it
18
open now
3
in phase 3
5
first study started
2004

How each study uses lutropin alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the lutropin alfa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
29 Nov 2000 · Luveris · EMEA/H/C/000292 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lutropin alfa
6
Recombinant human luteinizing hormone (r-hLH)
2

Brand

Luveris
9
Luveris® 75 IU
1
Luveris® 25 IU
1

In one entry with another drug

Given together, or one or the other

Follitropin alfa and lutropin alfa
2

Studies by the year they started

18 studies that test it; most in 2004 (2)

Studies that test lutropin alfa, by start year
YearStudies
20042
20061
20072
20081
20092
20122
20172
20211
20221
20231
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
4
Phase 3
5
Phase 4
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 9

Merck KGaA, Darmstadt, Germany (4) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (3) · EMD Serono (2) · Peter y. Liu (1) · D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology (1) · Sisli Hamidiye Etfal Training and Research Hospital (1) · University of Saskatchewan (1) · Ellen Greenblatt (1)

Often tested with

Tested in the same studies.

Follitropin alfa (8) · Ketoconazole (1) · Ganirelix (1) · Dexamethasone (1) · Cosyntropin (1) · Hydrocortisone (1) · Corifollitropin alfa (1) · Menotropins (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test lutropin alfa, phase 3 first.

Studies

Open first, then newest update. How each study uses lutropin alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Given beside what is tested · 1 — lutropin alfa is usual care or a partner of the new treatment

Codes

What other systems call lutropin alfa · ClinicalTrials.gg INT014681

  • UNII (FDA) 3JGY52XJNALUTROPIN ALFAConfirmed FDA, Wikidata
  • RxNorm 388084Confirmed FDA, Wikidata
  • Wikidata Q208360lutropin alfaConfirmed FDA, Wikidata
  • NCI Thesaurus C61818Lutropin AlfaOne source FDA
  • DrugBank DB00044One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.